As rare disease trials face persistent feasibility challenges, Bayesian designs are gaining momentum by enabling more ...

An international, randomized, double-blind, placebo-controlled Phase III study—the largest of its kind for mpox—found that ...

Despite a trend toward more patient-centered research, quality-of-life end points remain substantially underreported in phase ...

When Elise Felicione tried to design a clinical trial for a supplement, 5 things got in the way. It’s a lesson for the ...

Early clinical trials established the safety and feasibility of closed-loop insulin delivery, but the 2019 iDCL trial1 marked ...

Systematic review shows GLP 1 receptor agonists trials rarely assess dietary intake, highlighting a major evidence gap in nutrition outcomes.

Researchers at The Hospital for Sick Children (SickKids), working with international collaborators and youth and family ...

Clinical trials can vary in length depending on several factors. Here's what you need to know about how long clinical trials ...

Remote clinical pharmacist impact on reducing total cost of care in Enhancing Oncology Model–enrolled oncology practices. Electronic patient-reported outcome-based weight management versus usual care ...

Divergence in the post-progression interval suggests disparities may concentrate in subsequent-line therapy, surveillance, supportive care, or access to timely interventions outside trial ...

Some MS diets may help lower inflammation marker levels, but evidence from clinical trials remains limited, according to a ...